It’s been approximately one month since President Trump announced at a press conference that the administration is “looking into” federally reclassifying cannabis and that it would “make a determination over the next few weeks.”
|
Since then, neither the President nor his spokespersons have provided any further updates regarding either their intentions or their timeline. But while others wait, NORML is continuing to go about our work standing up for the rights of responsible cannabis consumers.
|
In recent days, NORML issued a primer highlighting the policy limitations associated with cannabis rescheduling and we’ve generated nearly 45,000 letters to the White House calling for marijuana descheduling – removing it entirely from the Controlled Substances Act, thereby allowing states the autonomy to set their own cannabis regulatory policies free from undue federal interference.
|
At the state level, NORML Chapters continue to push back against legislative efforts that seek to compromise consumers’ freedoms. For example, in California, we continue to advance efforts to repeal excessive taxation on cannabis products. In Nebraska, we continue to push back against regulators’ efforts to undermine the will of the voters who decided in favor of comprehensive medical cannabis access. The list goes on, and continues to grow, as new challenges to sensible cannabis policies arise.
|
Federally, we are working with Congressional leaders to advance critical legislation – such as support for veterans’ medical cannabis access and the advancement of the MORE Act – and to hold the line against attacks on the victories we have already secured.
|
Our efforts are made possible by your generosity. NORML doesn’t have multimillion dollar donors nor are we fueled by the multibillion dollar legal cannabis industry. We stand for – and we answer to you, the cannabis consumer. And right now we need your help.
|
|
